JAK2 and myeloproliferative neoplasm: Hence, to detect any latent MPN, screening for the JAK2 V617F mutation was recommended in patients with major idiopathic abdominal vein thrombosis who have normal blood counts [76], but not in patients with arterial and venous thrombosis at usual sites [77].